The present study aims to investigate the effects of paeoniflorin on MPGN in vivo and in vitro and explore the molecular mechanism related to the PI3K/AKT/GSK-3β pathway. This evidence concerns the gene GSK3B and primary membranoproliferative glomerulonephritis.